isenews
The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care. Patients with advanced lung or skin cancer who received a Covid-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who didn’t, researchers at the University of Florida and the University of […]
The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care.
Patients with advanced lung or skin cancer who received a Covid-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who didn’t, researchers at the University of Florida and the University of Texas MD Anderson Cancer Center reported in a study in the journal Nature.
First Appeared on
Source link
isenews.com @2024. All Rights Reserved.
